Category: Cancer Treatment
Global Cancer Treatment
-
Global Colorectal Cancer Drugs Market - 2024 - 2031
... Drugs Market is expected to exhibit a CAGR of 3.7% during the forecast period 2024-2031. The treatment of colorectal cancer typically involves a combination of surgery, radiation therapy, and chemotherapy. Besides, the treatment regimens for ... Read More
-
Global Oral Transmucosal Drugs Market- 2023-2030
... to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Oraltransmucosal drug administration was an alternative route in end-of-life care and palliative care during the COVID-19 pandemic. Oral transmucosal drug delivery is the systemic ... Read More
-
Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034 Including: 1) By Type: Product; Services 2) By Cancer: Lung Cancer; Breast Cancer; Colon Cancer 3)By Sample: Blood; Urine; Saliva 4) By End User: Hospitals; Diagnostic Centers Covering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Guardant Health Inc.; Illumina Inc.; Exact Sciences Corporation
... biopsy for cancer diagnostics market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how ... Read More
-
2025 Neoplasms Global Market Size & Growth Report with Updated Analysis & Forecasts
... countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling neoplasms (tumors) (c00-d49). The survey data is combined with ... Read More
-
Global Lung Cancer Therapeutics Market 2025-2029
... cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Point-Of-Care Molecular Diagnostics Global Market Report 2025 Including: 1) By Product And Service: Assays And Kits; Instruments And Analyzers; Software And Services 2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR); In Situ Hybridization; Sequencing 3) By Application: Respiratory Diseases; Hospital Acquired Infections (HAIs); Cancer/Oncology; Hepatitis; Hematology 4) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities Covering: Abbott Laboratories; F Hoffmann-La Roche Ltd.; BioMérieux SA; Danaher Corporation; Quidel Corporation
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030
... by many rising impacts with respect to improving cases of respiratory diseases around the world. Innovative technologies in diagnosis, such as molecular diagnostics and advanced imaging solutions, have also improved the accuracy and speed of ... Read More
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Nano-Magnetic Devices
... CAGR of 5.4% over the analysis period 2024-2030. Nano-Magnetic Sensors, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
Cancer Supportive Care
... at a CAGR of 2.2% over the analysis period 2024-2030. Opioids, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$11.1 Billion by the end of the ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Kaposi Sarcoma
... CAGR of 3.2% over the analysis period 2024-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the analysis period. ... Read More
-
Oncology Information Systems
... at a CAGR of 6.2% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$5.5 Billion by the end of ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029
... the drug development process has been one of the major drivers in the adoption of biosimulation tools. These tools predict how the drugs will behave inside the human body, potentially minimizing the requirements of extensive ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Intraoperative Radiation Therapy
... at a CAGR of 6.0% over the analysis period 2024-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$22.9 Million by the end ... Read More
Research Assistance
